Scalp Psoriasis Treatment With a Fiber Optic Comb
Sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
About this trial
Last updated 18 years ago
Study ID
R44AR044449
Status
Completed
Type
Interventional
Phase
Phase 1/Phase 2
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 23 years ago
What is this trial about?
This study will test the safety and effectiveness of a novel fiber optic device for treating
scalp psoriasis with ultraviolet (UV-B) light. A effective treatment is not currently
available for people with scalp psoriasis. Present methods for treating psoriasis with UV-B
light cannot be used for the scalp because hair is usually blocking the light from reaching
the affected skin. Our method overcomes this problem with the use of a comb that has optical
fibers to deliver light directly to the skin. We will evaluate this device in a clinical
setting and will use the results to tailor the design of the comb before producing it in
large quantities.
What are the participation requirements?
Inclusion Criteria
- Subjects of either sex and any race or ethnic background with chronic, stable, bilateral psoriasis of the scalp.
Exclusion Criteria
- Subjects who are currently taking systemic medications for psoriasis (e.g., methotrexate, retinoids).
- Subjects who are currently using or have used topical medications other than emollients in the past 6 weeks on their scalp.
- Patients with pustular psoriasis, known photosensitivity disorders, lupus erythematosus, or unstable major illnesses preventing participation in the study.